FOXA1 and prostate cancer: Using TENET, biomarkers and potential oncogenic drivers of breast cancer (e.g. GATA3, ESR1, FOXA1), prostate cancer (e.g. FOXA1, HOXC6, HOXB13), and kidney cancer (e.g. GLIS1, MAF, RUNX1) have been identified [14].